NCT06893731

Healthcare Utilization and Economic Burden of Cardiomyopathy in China

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 10,000 (estimated)
• Sponsor: China National Center for Cardiovascular Diseases · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cardiomyopathy is the most common inherited cardiovascular disease, showing family aggregation, and it has a huge psychological and economic burden on family members. In this study, the investigators collected clinical information and costs of patients hospitalized with cardiomyopathy and establish a database to evaluate the economic burden of cardiomyopathy.

Detailed description

This study conducted a retrospective survey of hospitalized patients with cardiomyopathy aged ≥18 years in 13 centers in China from March 1, 2017 to March1, 2022. The investigators collected demographic and clinical information as well as healthcare utilization data of patients hospitalized with cardiomyopathy so as to evaluate the economic burden of cardiomyopathy in China.

Conditions

• Cardiomyopathies
• Economic Burden

Timeline

• Start date: 2017-03-01
• Primary completion: 2022-03-01
• Completion: 2026-04-01
• First posted: 2025-03-25
• Last updated: 2025-04-17

Locations

1 site across 1 country: China